IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,680 | -39.1% | 53,556 | -5.7% | 0.00% | 0.0% |
| Q2 2023 | $399,872 | +46.5% | 56,800 | +129.9% | 0.00% | 0.0% |
| Q2 2022 | $273,000 | -62.7% | 24,704 | -35.5% | 0.00% | -50.0% |
| Q4 2021 | $731,000 | +45.3% | 38,284 | +88.0% | 0.00% | 0.0% |
| Q3 2021 | $503,000 | -75.3% | 20,369 | -73.9% | 0.00% | -75.0% |
| Q2 2021 | $2,033,000 | -2.2% | 78,127 | +19.0% | 0.01% | -11.1% |
| Q1 2021 | $2,078,000 | -0.7% | 65,638 | -6.1% | 0.01% | -43.8% |
| Q1 2020 | $2,093,000 | – | 69,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |